Literature DB >> 7479906

Fixing human factor IX (fIX): correction of a cryptic RNA splice enables the production of biologically active fIX in the mammary gland of transgenic mice.

F Yull1, G Harold, R Wallace, A Cowper, J Percy, I Cottingham, A J Clark.   

Abstract

Transgenic mice and sheep secrete only low levels of human factor IX in their milk because of an aberrant splicing of the transgene RNA in the mammary gland. Removal of the cryptic 3' splice site prevents this splicing and leads to the production of relatively high levels of factor IX. The purified protein is fully active showing that the mammary gland is capable of the efficient post-translational modification of this protein and that transgenic animals are a suitable means of its production.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7479906      PMCID: PMC40538          DOI: 10.1073/pnas.92.24.10899

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Expression of recombinant vitamin K-dependent proteins in mammalian cells: factors IX and VII.

Authors:  K L Berkner
Journal:  Methods Enzymol       Date:  1993       Impact factor: 1.600

2.  Targeting expression to the mammary gland: intronic sequences can enhance the efficiency of gene expression in transgenic mice.

Authors:  C B Whitelaw; A L Archibald; S Harris; M McClenaghan; J P Simons; A J Clark
Journal:  Transgenic Res       Date:  1991-12       Impact factor: 2.788

3.  Position-independent expression of the ovine beta-lactoglobulin gene in transgenic mice.

Authors:  C B Whitelaw; S Harris; M McClenaghan; J P Simons; A J Clark
Journal:  Biochem J       Date:  1992-08-15       Impact factor: 3.857

4.  Transgenic livestock as bioreactors: stable expression of human alpha-1-antitrypsin by a flock of sheep.

Authors:  A S Carver; M A Dalrymple; G Wright; D S Cottom; D B Reeves; Y H Gibson; J L Keenan; J D Barrass; A R Scott; A Colman
Journal:  Biotechnology (N Y)       Date:  1993-11

5.  High-level expression of a heterologous protein in the milk of transgenic swine using the cDNA encoding human protein C.

Authors:  W H Velander; J L Johnson; R L Page; C G Russell; A Subramanian; T D Wilkins; F C Gwazdauskas; C Pittius; W N Drohan
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

6.  Rescuing transgene expression by co-integration.

Authors:  A J Clark; A Cowper; R Wallace; G Wright; J P Simons
Journal:  Biotechnology (N Y)       Date:  1992-11

7.  High level expression of active human alpha-1-antitrypsin in the milk of transgenic sheep.

Authors:  G Wright; A Carver; D Cottom; D Reeves; A Scott; P Simons; I Wilmut; I Garner; A Colman
Journal:  Biotechnology (N Y)       Date:  1991-09

8.  Bovine alpha S1-casein gene sequences direct high level expression of active human urokinase in mouse milk.

Authors:  H Meade; L Gates; E Lacy; N Lonberg
Journal:  Biotechnology (N Y)       Date:  1990-05

9.  Inefficient processing of human protein C in the mouse mammary gland.

Authors:  W N Drohan; D W Zhang; R K Paleyanda; R Chang; M Wroble; W Velander; H Lubon
Journal:  Transgenic Res       Date:  1994-11       Impact factor: 2.788

10.  Characterization of recombinant human factor IX expressed in transgenic mice and in derived trans-immortalized hepatic cell lines.

Authors:  S Jallat; F Perraud; W Dalemans; A Balland; A Dieterle; T Faure; P Meulien; A Pavirani
Journal:  EMBO J       Date:  1990-10       Impact factor: 11.598

View more
  8 in total

Review 1.  The mammary gland as a bioreactor: expression, processing, and production of recombinant proteins.

Authors:  A J Clark
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-07       Impact factor: 2.673

2.  The changing role of cell culture in the generation of transgenic livestock.

Authors:  C B Whitelaw; E Farini; J Webster
Journal:  Cytotechnology       Date:  1999-09       Impact factor: 2.058

3.  Transgene rescue in the mammary gland is associated with transcription but does not require translation of BLG transgenes.

Authors:  F Yull; B Binas; G Harold; R Wallace; A J Clark
Journal:  Transgenic Res       Date:  1997-01       Impact factor: 2.788

4.  Comparable processing of beta-lactoglobulin pre-mRNA in cell culture and transgenic mouse models.

Authors:  G Donofrio; E Bignetti; A J Clark; C B Whitelaw
Journal:  Mol Gen Genet       Date:  1996-09-25

5.  Mammalian cDNA and prokaryotic reporter sequences silence adjacent transgenes in transgenic mice.

Authors:  A J Clark; G Harold; F E Yull
Journal:  Nucleic Acids Res       Date:  1997-03-01       Impact factor: 16.971

6.  Rescue of an MMTV transgene by co-integration reveals novel locus control properties of the ovine beta-lactoglobulin gene that confer locus commitment to heterogeneous tissues.

Authors:  B Langley; J L Vilotte; M G Stinnakre; C B Whitelaw; P J L'Huillier
Journal:  Transgenic Res       Date:  1998-05       Impact factor: 2.788

7.  Coagulation Factor IX for Hemophilia B Therapy.

Authors:  N A Orlova; S V Kovnir; I I Vorobiev; A G Gabibov
Journal:  Acta Naturae       Date:  2012-04       Impact factor: 1.845

8.  On the use of post-transcriptional processing elements in transgenes.

Authors:  C B A Whitelaw; L Hiripi; E Farini; M L Opsahl; Z Bosze
Journal:  Transgenic Res       Date:  2004-02       Impact factor: 2.788

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.